BDTX

BLACK DIAMOND THERAPEUTICS I

BDTX·09203E105·US·Common Stock·Healthcare - Biotechnology-13D/G

BDTX (BLACK DIAMOND THERAPEUTICS I) is held by 63 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($3.5M), DIMENSIONAL FUND ADVISORS LP ($2.8M), BlackRock, Inc. ($2.4M). Net institutional sentiment: Mixed.

63
Holders
Avg rating(14 Elite)
$32.6M
Total Value
50% (69)
Fund Consensus
30 buying - 30 selling
BDTXSmart Money Verdict
View all
Held by 63 funds
14 elite
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.7.0%Jul 8, 2026
ActivistVPVestal Point Capital, LP1.5%Feb 17, 2026
ActivistBlackRock, Inc.BlackRock, Inc.4.5%Apr 29, 2025
ActivistBBBB Biotech AG4.8%Mar 21, 2025
InsiderBVBIOTECH GROWTH N VSell $2.1MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $583KMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $2.3MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $4.0MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $837KMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $1.1MMar 19, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.6M(+73.1%)$3.5M0.0%-30.28%
40
Increased
1.3M(+51.9%)$2.8M0.0%-24.13%
37
Increased
1.1M(+24.6%)$2.4M0.0%-12.37%
22
Increased
1.1M(+61.7%)$2.3M0.0%-25.73%
38
Increased
844,835(+139.7%)$1.8M0.0%-19.72%
42
Decreased
836,266(-24.7%)$1.8M0.0%-35.17%
0
Decreased
834,570(-19.8%)$1.8M0.0%-43.42%
0
Increased
684,418(+110.4%)$1.5M0.0%-20.19%
41
Increased
623,827(+15.3%)$1.3M0.0%-13.92%
29
Increased
564,838(+119.2%)$1.2M0.0%-27.94%
41
Increased
559,700(+330.4%)$1.2M0.0%-20.92%
41
Increased
536,575(+6.1%)$1.1M0.0%-77.88%
27
New
510,811$1.1M0.0%-16.96%
35
Increased
502,652(+18.1%)$1.1M0.0%-22.38%
29
Decreased
464,708(-1.7%)$989,8280.0%-56.60%
0
Decreased
363,921(-44.5%)$775,1520.0%-29.73%
0
Increased
278,645(+1.3%)$593,5150.0%-32.50%
25
New
230,177$490,2770.0%-16.96%
33
Unchanged
213,513$454,7830.0%-53.97%
0
Increased
211,400(+4.1%)$450,2820.0%-23.06%
25

Showing 1-20 of 69

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used